Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FHN
|
D Bryan Jordan
Chairman, President & CEO |
BUY
Open market or private purchase
|
Direct | 25,000 Added 3.78% |
$443,750
$17.75 p/Share
|
Jul 31
2018 |
DHR
|
Thomas Patrick Joyce Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 10,289 Reduced 5.97% |
$1,051,021
$102.15 p/Share
|
Jul 31
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 655 Added 0.0% |
$2,758
$4.21 p/Share
|
Jul 31
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jul 31
2018 |
STKS
|
David Kanen
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,647 Added 0.05% |
$4,612
$2.8 p/Share
|
Jul 31
2018 |
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 47,000 Added 0.16% |
$512,300
$10.9 p/Share
|
Jul 31
2018 |
ADI
|
Peter Real
SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,595 Reduced 25.25% |
$439,650
$95.68 p/Share
|
Jul 31
2018 |
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 205,000 Reduced 0.17% |
$20,282,701
$98.94 p/Share
|
Jul 31
2018 |
MRK
|
Kenneth C Frazier
Executive Chair |
SELL
Open market or private sale
|
Direct | 228,091 Reduced 24.3% |
$14,825,915
$65.0 p/Share
|
Jul 31
2018 |
DHR
|
Mitchell P Rales
Chairman of Exec. Committee |
BUY
Open market or private purchase
|
Indirect | 1,080 Added 33.96% |
$110,506
$102.32 p/Share
|
Jul 31
2018 |
UPS
|
Kathleen M. Gutmann
Pres Intl, Healthcare and SCS |
SELL
Open market or private sale
|
Direct | 1,700 Reduced 4.61% |
$203,864
$119.92 p/Share
|
Jul 31
2018 |
GL
|
Robert W Ingram
Director |
SELL
Open market or private sale
|
Direct | 1,497 Reduced 4.86% |
$132,365
$88.42 p/Share
|
Jul 31
2018 |
CB
|
Paul J Krump
Vice Chairman, Chubb Group* |
SELL
Open market or private sale
|
Indirect | 126 Reduced 100.0% |
$17,645
$140.04 p/Share
|
Jul 31
2018 |
HWC
|
John M Hairston
President & CEO |
SELL
Open market or private sale
|
Indirect | 15,941 Reduced 86.38% |
$799,919
$50.18 p/Share
|
Jul 31
2018 |
KF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,300 Reduced 0.52% |
$159,788
$37.16 p/Share
|
Jul 31
2018 |
KWR
|
Jan Nieman
VP/GL - Grease, FP, GS, Mktg. |
SELL
Open market or private sale
|
Direct | 524 Reduced 9.92% |
$89,080
$170.0 p/Share
|
Jul 31
2018 |
KWR
|
Joseph A Berquist
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 4.2% |
$85,420
$170.84 p/Share
|
Jul 31
2018 |
TZOO
|
Azzurro Capital Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 19,250 Reduced 0.29% |
$254,485
$13.22 p/Share
|
Jul 31
2018 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 0.18% |
$13,815
$3.07 p/Share
|
Jul 31
2018 |
RTX
|
Robert J. Bailey
Corporate VP, Controller |
SELL
Open market or private sale
|
Direct | 828 Reduced 41.4% |
$111,573
$134.75 p/Share
|
Jul 31
2018 |
TXN
|
Stephen A. Anderson
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 25,318 Reduced 19.3% |
$2,832,578
$111.88 p/Share
|
Jul 31
2018 |
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 403 Reduced 0.16% |
$94,302
$234.0 p/Share
|
Jul 31
2018 |
NDLS
|
Public Sector Pension Investment Board |
SELL
Open market or private sale
|
Indirect | 360,996 Reduced 5.48% |
$3,429,462
$9.5 p/Share
|
Jul 31
2018 |
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,692 Added 0.01% |
$16,906
$6.28 p/Share
|
Jul 31
2018 |
EGN
|
Icahn Carl C |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 1.68% |
$7,407,000
$74.07 p/Share
|
Jul 31
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,700 Added 0.04% |
$46,900
$7.0 p/Share
|
Jul 31
2018 |
EPE
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 258,794 Reduced 0.24% |
$558,995
$2.16 p/Share
|
Jul 31
2018 |
STX
|
Value Act Holdings, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 500,000 Added 2.14% |
$26,325,001
$52.65 p/Share
|
Jul 31
2018 |
BBQ
|
David Kanen
Director |
BUY
Open market or private purchase
|
Indirect | 1,218 Added 0.12% |
$7,856
$6.45 p/Share
|
Jul 31
2018 |
MNI
|
Chatham Asset Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.01% |
$985
$9.85 p/Share
|
Jul 31
2018 |
WST
|
Patrick J Zenner |
BUY
Open market or private purchase
|
Direct | 57 Added 0.09% |
$6,301
$110.55 p/Share
|
Jul 31
2018 |
TZOO
|
Azzurro Capital Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 28,150 Reduced 0.43% |
$370,736
$13.17 p/Share
|
Jul 30
2018 |
EGN
|
Icahn Carl C |
BUY
Open market or private purchase
|
Indirect | 60,382 Added 1.04% |
$4,480,948
$74.21 p/Share
|
Jul 30
2018 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 700 Added 0.06% |
$5,621
$8.03 p/Share
|
Jul 30
2018 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.08% |
$6,540
$3.27 p/Share
|
Jul 30
2018 |
INTC
|
Navin Shenoy
EVP, GM - Data Platforms Group |
SELL
Open market or private sale
|
Direct | 601 Reduced 1.44% |
$28,662
$47.69 p/Share
|
Jul 30
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,189 Added 0.1% |
$127,323
$7.0 p/Share
|
Jul 30
2018 |
EPE
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 271,615 Reduced 0.25% |
$600,269
$2.21 p/Share
|
Jul 30
2018 |
ABT
|
Sharon J Bracken
Senior Vice President |
SELL
Open market or private sale
|
Direct | 615 Reduced 1.49% |
$40,073
$65.16 p/Share
|
Jul 30
2018 |
NKE
|
Monique S. Matheson
EVP: CHRO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.52% |
$760,700
$76.07 p/Share
|
Jul 30
2018 |
INTC
|
Robert Holmes Swan
CEO |
BUY
Open market or private purchase
|
Direct | 5,243 Added 6.5% |
$250,039
$47.69 p/Share
|
Jul 30
2018 |
AROW
|
Raymond F O'Conor
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.15% |
$38,890
$38.89 p/Share
|
Jul 30
2018 |
ASB
|
Philip B Flynn
President & CEO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 1.84% |
$277,500
$27.75 p/Share
|
Jul 30
2018 |
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.46% |
$2,284,000
$45.68 p/Share
|
Jul 30
2018 |
SFNC
|
Russell William Teubner |
SELL
Open market or private sale
|
Indirect | 662 Reduced 100.0% |
$19,959
$30.15 p/Share
|
Jul 30
2018 |
SFNC
|
Russell William Teubner |
SELL
Open market or private sale
|
Direct | 1,410 Reduced 48.49% |
$42,441
$30.1 p/Share
|
Jul 30
2018 |
TRU
|
Gerald M Mc Carthy Jr
EVP - Healthcare |
SELL
Open market or private sale
|
Direct | 62,752 Reduced 62.88% |
$4,430,919
$70.61 p/Share
|
Jul 30
2018 |
R
|
Art A Garcia
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,412 Reduced 21.32% |
$262,110
$76.82 p/Share
|
Jul 30
2018 |
PEN
|
James Robert Pray
President, International |
SELL
Open market or private sale
|
Indirect | 8,125 Reduced 0.32% |
$1,121,737
$138.06 p/Share
|
Jul 30
2018 |
DHR
|
Thomas Patrick Joyce Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 94,624 Reduced 34.23% |
$9,637,454
$101.85 p/Share
|
Jul 30
2018 |